Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer.
Guilloteau A, Abrahamowicz M, Boussari O, Jooste V, Aparicio T, Quantin C, Le Malicot K, Binquet C. Guilloteau A, et al. Among authors: boussari o. BMC Med Res Methodol. 2021 Jan 9;21(1):14. doi: 10.1186/s12874-020-01202-9. BMC Med Res Methodol. 2021. PMID: 33422006 Free PMC article. Clinical Trial.
A new approach to estimate time-to-cure from cancer registries data.
Boussari O, Romain G, Remontet L, Bossard N, Mounier M, Bouvier AM, Binquet C, Colonna M, Jooste V. Boussari O, et al. Cancer Epidemiol. 2018 Apr;53:72-80. doi: 10.1016/j.canep.2018.01.013. Epub 2018 Feb 4. Cancer Epidemiol. 2018. PMID: 29414635
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials.
Breton C, Aparicio T, Le Malicot K, Ducreux M, Lecomte T, Bachet JB, Taieb J, Legoux JL, De Gramont A, Bennouna J, Bouché O, Boussari O, Manfredi S, Gornet JM. Breton C, et al. Among authors: boussari o. Eur J Cancer. 2021 Aug;153:40-50. doi: 10.1016/j.ejca.2021.04.040. Epub 2021 Jun 12. Eur J Cancer. 2021. PMID: 34130228
Net survival in recurrence-free colon cancer patients.
Drouillard A, Bouvier AM, Boussari O, Romain G, Manfredi S, Lepage C, Faivre J, Jooste V. Drouillard A, et al. Among authors: boussari o. Cancer Epidemiol. 2019 Aug;61:124-128. doi: 10.1016/j.canep.2019.06.001. Epub 2019 Jun 15. Cancer Epidemiol. 2019. PMID: 31212224
Modeling excess hazard with time-to-cure as a parameter.
Boussari O, Bordes L, Romain G, Colonna M, Bossard N, Remontet L, Jooste V. Boussari O, et al. Biometrics. 2021 Dec;77(4):1289-1302. doi: 10.1111/biom.13361. Epub 2020 Sep 12. Biometrics. 2021. PMID: 32869288
Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery.
Terlizzi M, Buscail E, Boussari O, Adgié S, Leduc N, Terrebonne E, Smith D, Blanc JF, Lapuyade B, Laurent C, Chiche L, Belleannée G, Le Malicot K, Trouette R, Pouypoudat C, Vendrely V. Terlizzi M, et al. Among authors: boussari o. Acta Oncol. 2021 Sep;60(9):1114-1121. doi: 10.1080/0284186X.2021.1944662. Epub 2021 Jul 1. Acta Oncol. 2021. PMID: 34197269
Time-to-cure and cure proportion in solid cancers in France. A population based study.
Romain G, Boussari O, Bossard N, Remontet L, Bouvier AM, Mounier M, Iwaz J, Colonna M, Jooste V; French Network of Cancer Registries (FRANCIM). Romain G, et al. Among authors: boussari o. Cancer Epidemiol. 2019 Jun;60:93-101. doi: 10.1016/j.canep.2019.02.006. Epub 2019 Mar 30. Cancer Epidemiol. 2019. PMID: 30933890
25 results